1. A novel photosensitizer based on hypocrellin B activated by cysteine over-expressed in cancer cells.
- Author
-
Ishida F, Onishi R, Takahashi D, and Toshima K
- Subjects
- Humans, HeLa Cells, A549 Cells, Molecular Structure, Drug Screening Assays, Antitumor, Cell Survival drug effects, Photochemotherapy, Quinones chemistry, Quinones pharmacology, Quinones chemical synthesis, Photosensitizing Agents pharmacology, Photosensitizing Agents chemistry, Photosensitizing Agents chemical synthesis, Perylene chemistry, Perylene analogs & derivatives, Perylene pharmacology, Perylene chemical synthesis, Cysteine chemistry, Antineoplastic Agents pharmacology, Antineoplastic Agents chemistry, Antineoplastic Agents chemical synthesis
- Abstract
L-Cysteine (Cys)-activatable photosensitizer 3 was designed and synthesized based on hypocrellin B (1). Cys is a novel tumor-associated biomarker. 3 exhibited negligible photosensitizing ability without Cys. However, when 1 was released from 3 by reaction with Cys, the photosensitizing activity was restored. Furthermore, 3 showed selective and effective photo-cytotoxicity against only cancer cells such as HeLa and A549 cells that highly express Cys when irradiated with 660 nm light, which is inside the phototherapeutic window.
- Published
- 2024
- Full Text
- View/download PDF